Details for Patent: 7,220,247
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 7,220,247 protect, and when does it expire?
Patent 7,220,247 protects ZOLADEX and is included in two NDAs.
This patent has fifty patent family members in thirty-three countries.
Summary for Patent: 7,220,247
Title: | Automatically operable safety shield system for syringes |
Abstract: | An automatically operable safety shield system for use with a syringe that comprises an inner holder in which said syringe may be inserted and an outer shield mounted outwards from the inner holder axially movable between retracted and extended positions in which a spring positioned between said inner holder and said outer shield urging the outer shield to its extended position and the inner holder having at least one first opening, distally thereto, at least one first indentation, and the outer shield having at least one first stop member engageable with the opening when the outer shield is in the retracted position engageable with the first indentation when the outer shield is in the extended position and the outer shield may be released from its retracted position by action of a trigger positioned within the inner holder or by protrusion on the syringe plunger. |
Inventor(s): | Shaw; Derek J (Macclesfield, GB), Law; Brian R (Leicester, GB) |
Assignee: | AstraZeneca AB (Sodertalje, SE) |
Application Number: | 10/815,014 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 7,220,247
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tersera | ZOLADEX | goserelin acetate | IMPLANT;IMPLANTATION | 019726-001 | Dec 29, 1989 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | ||||
Tersera | ZOLADEX | goserelin acetate | IMPLANT;IMPLANTATION | 020578-001 | Jan 11, 1996 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,220,247
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
United Kingdom | 0003790.3 | Feb 18, 2000 |
International Family Members for US Patent 7,220,247
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 027445 | See Plans and Pricing | |||
Austria | 344075 | See Plans and Pricing | |||
Australia | 3209901 | See Plans and Pricing | |||
Australia | 770373 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |